Loading organizations...
Key people at Alfresa.
Alfresa Holdings Corporation is a comprehensive Japanese healthcare enterprise, focusing on distributing and manufacturing medical products. Its core offerings include ethical pharmaceuticals, diagnostic reagents, and medical devices. Through robust supply chain services, Alfresa delivers crucial supplies to the healthcare sector, manufacturing and marketing self-medication products.
Alfresa Holdings Corporation was established on September 29, 2003, emerging from a strategic consolidation of existing healthcare entities. The company formed via a stock transfer involving AZWELL Inc. and Fukujin Co., Ltd. This structure reflects an insight into unifying and optimizing distribution and manufacturing capabilities within the Japanese healthcare market.
The company serves hospitals, clinics, and pharmacies, providing essential pharmaceuticals, diagnostic tools, and medical equipment. Alfresa's vision, rooted in its corporate philosophy, strives to contribute to "a fresh life for all." This mission guides continuous efforts to ensure access to vital healthcare products, fostering improved health outcomes and supporting the medical ecosystem.
Key people at Alfresa.
Alfresa has 1 tracked investment across 1 company. The latest tracked deal is $12.7M Series B in Metcela in January 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 4, 2021 | Metcela | $12.7M Series B | University OF Tokyo Edge Capital | DAI Ichi Life, Japan Lifeline, KSP, Makoto Capital, Sony, Tsukuba Exceed Fund |